Genetic findings in miscarriages and their relation to the number of previous miscarriages

Por Gomez, R., Hafezi, N., Amrani, M., Schweiger, S., Dewenter, M. K., Thomas, P., Lieb, C., Hasenburg, A., Skala, C.
Publicado no Arch Gynecol Obstet (2020)

Specific induction of pp125 focal adhesion kinase in human breast cancer

Por Watermann, D O, Gabriel, B, Jäger, M, Orlowska-Volk, M, Hasenburg, A, zur Hausen, A, Gitsch, G, Stickeler, E
Publicado em 2005

EndoPredict(®) in early hormone receptor-positive, HER2-negative breast cancer

Por Almstedt, K., Mendoza, S., Otto, M., Battista, M. J., Steetskamp, J., Heimes, A. S., Krajnak, S., Poplawski, A., Gerhold-Ay, A., Hasenburg, A., Denkert, C., Schmidt, M.
Publicado no Breast Cancer Res Treat (2020)

Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes

Por Stumpf, M, Hasenburg, A, Riener, M-O, Jütting, U, Wang, C, Shen, Y, Orlowska-Volk, M, Fisch, P, Wang, Z, Gitsch, G, Werner, M, Lassmann, S
Publicado em 2009

Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study

Por Krajnak, S., Schnatz, C., Almstedt, K., Brenner, W., Haertner, F., Heimes, A.-S., Lebrecht, A., Makris, G.-M., Schwab, R., Hasenburg, A., Schmidt, M., Battista, M. J.
Publicado no Breast Cancer Res Treat (2020)

A Review of Integrative Medicine in Gynaecological Oncology

Por Kalder, M., Müller, T., Fischer, D., Müller, A., Bader, W., Beckmann, M. W., Brucker, C., Hack, C. C., Hanf, V., Hasenburg, A., Hein, A., Jud, S., Kiechle, M., Klein, E., Paepke, D., Rotmann, A., Schütz, F., Dobos, G., Voiß, P., Kümmel, S.
Publicado no Geburtshilfe Frauenheilkd (2016)

Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

Por Stephen, J, Murray, G, Cameron, D A, Thomas, J, Kunkler, I H, Jack, W, Kerr, G R, Piper, T, Brookes, C L, Rea, D W, van de Velde, C J H, Hasenburg, A, Markopoulos, C, Dirix, L, Seynaeve, C, Bartlett, J M S
Publicado no Br J Cancer (2014)

Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

Por Bartlett, J M S, Brookes, C L, Piper, T, van de Velde, C J H, Stocken, D, Lyttle, N, Hasenburg, A, Quintayo, M A, Kieback, D G, Putter, H, Markopoulos, C, Kranenbarg, E M-K, Mallon, E A, Dirix, L Y, Seynaeve, C, Rea, D W
Publicado em 2013

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study

Por Trillsch, F, Mahner, S, Vettorazzi, E, Woelber, L, Reuss, A, Baumann, K, Keyver-Paik, M-D, Canzler, U, Wollschlaeger, K, Forner, D, Pfisterer, J, Schroeder, W, Muenstedt, K, Richter, B, Fotopoulou, C, Schmalfeldt, B, Burges, A, Ewald-Riegler, N, de Gregorio, N, Hilpert, F, Fehm, T, Meier, W, Hillemanns, P, Hanker, L, Hasenburg, A, Strauss, H-G, Hellriegel, M, Wimberger, P, Kommoss, S, Kommoss, F, Hauptmann, S, du Bois, A
Publicado no Br J Cancer (2015)

S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 – AWMF registration number: 032/035OL, June 2013

Por Wagner, U., Harter, P., Hilpert, F., Mahner, S., Reuß, A., du Bois, A., Petru, E., Meier, W., Ortner, P., König, K., Lindel, K., Grab, D., Piso, P., Ortmann, O., Runnebaum, I., Pfisterer, J., Lüftner, D., Frickhofen, N., Grünwald, F., Maier, B. O., Diebold, J., Hauptmann, S., Kommoss, F., Emons, G., Radeleff, B., Gebhardt, M., Arnold, N., Calaminus, G., Weisse, I., Weis, J., Sehouli, J., Fink, D., Burges, A., Hasenburg, A., Eggert, C.
Publicado em 2013